SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics IPO Watchlist Monthly Activity About API

SEC Comment Letter for Varex Imaging Corp (VREX) (CIK 0001681622) (VREX) — Oct 27, 2016

Varex Imaging Corp (VREX) (CIK 0001681622)
Date: Oct. 27, 2016 · CIK: 0001681622 · Accession: 0000000000-16-098726

AI Filing Summary & Sentiment

File numbers found in text: 001-37860

Date
October 27, 2016
Author
/s/ Daniel Morris for
Form
UPLOAD
Company
Varex Imaging Corp (VREX) (CIK 0001681622)

Letter

Mail Stop 3030 October 27, 2016 Sunny S. Sanyal President and Chief Executive Officer Varex Imaging Corporation 1678 S. Pioneer Road Salt Lake City, Utah 84014

Re: Varex Imaging Corporation Amendment No.1 to Registration Statement on Form 10 -12B Filed October 11, 2016 File No. 001-37860

Dear Mr. Sanyal :

We have reviewed your filing an d have the following comments. In some of our comments, we may ask you to provide us with information so we may better understand your disclosure.

Please respond to these comments within ten busine ss days by providing the requested information or advis e us as soon as possible when you will respond. If you do not believe our comments apply to your facts and circumstances, please tell us why in your response.

After reviewing your response and any amendment you may file in response to these comments , we may have additional comments.

Form 10

1. We note your responses to prior comments 1, 8 and 11. Please be advised that we may have further comments after you provide the information and exhibits in a future amendment in response to those comments.

Exhibit 99.1

Reasons for the Separation, page 14

2. We note your response to prior comment 4, howev er, your related revised disclosure does not appear to add any substantive disclosure as to why the Varian Medical board determined to complete the spin -off at this time if the conditions supporting the decision have existed previously. Please revise your disclosure as appropriate.

Sunny S. Sanyal Varex Imaging Corporation October 2 7, 2016 Page 2

You may contact Dennis Hult at (202) 551 -3618 or Kate Tillan, Assistant Chief Accountant, at (202) 551 -3604 if you have questions regarding comments on the financial statements and related matters. Please contact Tim Buchmille r at (202) 551 -3635 or Daniel Morris, Special Counsel, at (202) 551 -3314 with any other questions.

Sincerely,
/s/ Daniel Morris for

Show Raw Text
Mail Stop 3030

October 27, 2016

Sunny S. Sanyal
President and Chief Executive Officer
Varex Imaging Corporation
1678 S. Pioneer Road
Salt Lake City, Utah 84014

Re: Varex Imaging Corporation
Amendment No.1 to Registration Statement on Form 10 -12B
Filed October 11, 2016
  File No. 001-37860

Dear Mr. Sanyal :

We have reviewed your filing an d have the following comments.  In some of our
comments, we may ask you to provide us with information so we may better understand your
disclosure.

Please respond to these comments  within ten busine ss days by providing the requested
information or advis e us as soon as possible when you will respond.  If you do not believe our
comments apply to your facts and circumstances, please tell us why in your response.

After reviewing your response and any amendment you may file in response to these
comments , we may have  additional comments.

Form 10

1. We note your responses to prior comments 1, 8 and 11.  Please be advised that we may have
further comments after you provide the information and exhibits in a future amendment in
response to those comments.

Exhibit 99.1

Reasons for the Separation, page 14

2. We note your response to prior comment 4, howev er, your related revised disclosure does
not appear to add any substantive disclosure as to why the Varian Medical board
determined to complete the spin -off at this time if the conditions supporting the decision
have existed previously.  Please revise your  disclosure as appropriate.

Sunny S. Sanyal
Varex Imaging Corporation
October 2 7, 2016
Page 2

 You may contact Dennis Hult at (202) 551 -3618 or Kate Tillan, Assistant Chief
Accountant, at (202) 551 -3604 if you have questions regarding comments on the financial
statements and related matters.  Please contact Tim Buchmille r at (202) 551 -3635 or Daniel
Morris, Special Counsel, at (202) 551 -3314 with any other questions.

Sincerely,

 /s/ Daniel Morris for

 Amanda Ravitz
Assistant Director
Office of Electronics and Machinery

cc: Ronald C. Chen, Esq.
 Wachtell, Lipton, Rosen & Katz